Cardiovascular complications associated with chronic active epstein-barr virus infection

Jun Muneuchi, Shouichi Ohga, Masataka Ishimura, Kazuyuki Ikeda, Kenichiro Yamaguchi, Akihiko Nomura, Hidetoshi Takada, Yasunobu Abe, Toshiro Hara

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

This study aimed to assess the outcome of cardiovascular diseases for patients with chronic active Epstein-Barr virus infection (CAEBV). The study enrolled 15 patients (7 boys and 8 girls) who fulfilled the diagnostic criteria for CAEBV, including 10 patients with T-cell type and 3 patients with natural killer (NK)-cell type. The median age at the CAEBV onset was 6.3 years (range, 1.2-17.8 years). Regular cardiologic studies were performed during the median follow-up period of 8 years (range, 2-20 years). Nine patients (60%) had cardiac diseases including coronary artery lesion (CAL) (n = 4, 44%), decreased left ventricular ejection fraction and pericardial effusion in (n = 3, 33%), complete atrioventricular block (n = 1), and sudden arrest (n = 1). The frequency of fever (78%, p = 0.04) or cytopenias (100%, p = 0.01), as the major symptom among patients with cardiac complications, was higher than among those without complications. The median time from disease onset to detection of CAL was 3.4 years (range, 1.8-8.6 years). The mean z-score increased to 3.98. Seven patients (78%) with cardiac complications died of disease progression, hematopoietic stem cell transplantation-related events, or both. In two patients, CAL regressed after allogeneic cord blood transplantation. Among CAEBV patients, CAL was the most common cardiac complication and could not be controlled without the eradication of EBV-infected T- and NK-cells.

Original languageEnglish
Pages (from-to)274-281
Number of pages8
JournalPediatric Cardiology
Volume30
Issue number3
DOIs
Publication statusPublished - Apr 1 2009

Fingerprint

Epstein-Barr Virus Infections
Coronary Vessels
Natural Killer T-Cells
Pericardial Effusion
Atrioventricular Block
Hematopoietic Stem Cell Transplantation
Human Herpesvirus 4
Fetal Blood
Natural Killer Cells
Stroke Volume
Disease Progression
Heart Diseases
Fever
Cardiovascular Diseases
Transplantation
T-Lymphocytes

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this

Cardiovascular complications associated with chronic active epstein-barr virus infection. / Muneuchi, Jun; Ohga, Shouichi; Ishimura, Masataka; Ikeda, Kazuyuki; Yamaguchi, Kenichiro; Nomura, Akihiko; Takada, Hidetoshi; Abe, Yasunobu; Hara, Toshiro.

In: Pediatric Cardiology, Vol. 30, No. 3, 01.04.2009, p. 274-281.

Research output: Contribution to journalArticle

Muneuchi, J, Ohga, S, Ishimura, M, Ikeda, K, Yamaguchi, K, Nomura, A, Takada, H, Abe, Y & Hara, T 2009, 'Cardiovascular complications associated with chronic active epstein-barr virus infection', Pediatric Cardiology, vol. 30, no. 3, pp. 274-281. https://doi.org/10.1007/s00246-008-9343-8
Muneuchi, Jun ; Ohga, Shouichi ; Ishimura, Masataka ; Ikeda, Kazuyuki ; Yamaguchi, Kenichiro ; Nomura, Akihiko ; Takada, Hidetoshi ; Abe, Yasunobu ; Hara, Toshiro. / Cardiovascular complications associated with chronic active epstein-barr virus infection. In: Pediatric Cardiology. 2009 ; Vol. 30, No. 3. pp. 274-281.
@article{961d2ad3978f4ab1a51f20bd97a9b010,
title = "Cardiovascular complications associated with chronic active epstein-barr virus infection",
abstract = "This study aimed to assess the outcome of cardiovascular diseases for patients with chronic active Epstein-Barr virus infection (CAEBV). The study enrolled 15 patients (7 boys and 8 girls) who fulfilled the diagnostic criteria for CAEBV, including 10 patients with T-cell type and 3 patients with natural killer (NK)-cell type. The median age at the CAEBV onset was 6.3 years (range, 1.2-17.8 years). Regular cardiologic studies were performed during the median follow-up period of 8 years (range, 2-20 years). Nine patients (60{\%}) had cardiac diseases including coronary artery lesion (CAL) (n = 4, 44{\%}), decreased left ventricular ejection fraction and pericardial effusion in (n = 3, 33{\%}), complete atrioventricular block (n = 1), and sudden arrest (n = 1). The frequency of fever (78{\%}, p = 0.04) or cytopenias (100{\%}, p = 0.01), as the major symptom among patients with cardiac complications, was higher than among those without complications. The median time from disease onset to detection of CAL was 3.4 years (range, 1.8-8.6 years). The mean z-score increased to 3.98. Seven patients (78{\%}) with cardiac complications died of disease progression, hematopoietic stem cell transplantation-related events, or both. In two patients, CAL regressed after allogeneic cord blood transplantation. Among CAEBV patients, CAL was the most common cardiac complication and could not be controlled without the eradication of EBV-infected T- and NK-cells.",
author = "Jun Muneuchi and Shouichi Ohga and Masataka Ishimura and Kazuyuki Ikeda and Kenichiro Yamaguchi and Akihiko Nomura and Hidetoshi Takada and Yasunobu Abe and Toshiro Hara",
year = "2009",
month = "4",
day = "1",
doi = "10.1007/s00246-008-9343-8",
language = "English",
volume = "30",
pages = "274--281",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Cardiovascular complications associated with chronic active epstein-barr virus infection

AU - Muneuchi, Jun

AU - Ohga, Shouichi

AU - Ishimura, Masataka

AU - Ikeda, Kazuyuki

AU - Yamaguchi, Kenichiro

AU - Nomura, Akihiko

AU - Takada, Hidetoshi

AU - Abe, Yasunobu

AU - Hara, Toshiro

PY - 2009/4/1

Y1 - 2009/4/1

N2 - This study aimed to assess the outcome of cardiovascular diseases for patients with chronic active Epstein-Barr virus infection (CAEBV). The study enrolled 15 patients (7 boys and 8 girls) who fulfilled the diagnostic criteria for CAEBV, including 10 patients with T-cell type and 3 patients with natural killer (NK)-cell type. The median age at the CAEBV onset was 6.3 years (range, 1.2-17.8 years). Regular cardiologic studies were performed during the median follow-up period of 8 years (range, 2-20 years). Nine patients (60%) had cardiac diseases including coronary artery lesion (CAL) (n = 4, 44%), decreased left ventricular ejection fraction and pericardial effusion in (n = 3, 33%), complete atrioventricular block (n = 1), and sudden arrest (n = 1). The frequency of fever (78%, p = 0.04) or cytopenias (100%, p = 0.01), as the major symptom among patients with cardiac complications, was higher than among those without complications. The median time from disease onset to detection of CAL was 3.4 years (range, 1.8-8.6 years). The mean z-score increased to 3.98. Seven patients (78%) with cardiac complications died of disease progression, hematopoietic stem cell transplantation-related events, or both. In two patients, CAL regressed after allogeneic cord blood transplantation. Among CAEBV patients, CAL was the most common cardiac complication and could not be controlled without the eradication of EBV-infected T- and NK-cells.

AB - This study aimed to assess the outcome of cardiovascular diseases for patients with chronic active Epstein-Barr virus infection (CAEBV). The study enrolled 15 patients (7 boys and 8 girls) who fulfilled the diagnostic criteria for CAEBV, including 10 patients with T-cell type and 3 patients with natural killer (NK)-cell type. The median age at the CAEBV onset was 6.3 years (range, 1.2-17.8 years). Regular cardiologic studies were performed during the median follow-up period of 8 years (range, 2-20 years). Nine patients (60%) had cardiac diseases including coronary artery lesion (CAL) (n = 4, 44%), decreased left ventricular ejection fraction and pericardial effusion in (n = 3, 33%), complete atrioventricular block (n = 1), and sudden arrest (n = 1). The frequency of fever (78%, p = 0.04) or cytopenias (100%, p = 0.01), as the major symptom among patients with cardiac complications, was higher than among those without complications. The median time from disease onset to detection of CAL was 3.4 years (range, 1.8-8.6 years). The mean z-score increased to 3.98. Seven patients (78%) with cardiac complications died of disease progression, hematopoietic stem cell transplantation-related events, or both. In two patients, CAL regressed after allogeneic cord blood transplantation. Among CAEBV patients, CAL was the most common cardiac complication and could not be controlled without the eradication of EBV-infected T- and NK-cells.

UR - http://www.scopus.com/inward/record.url?scp=64249120333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64249120333&partnerID=8YFLogxK

U2 - 10.1007/s00246-008-9343-8

DO - 10.1007/s00246-008-9343-8

M3 - Article

C2 - 19184184

AN - SCOPUS:64249120333

VL - 30

SP - 274

EP - 281

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 3

ER -